Video

New Delivery Option for Ketamine

Author(s):

Jeffrey Becker, MD

How can new formulations of ketamine impact patient care?

Jeffrey Becker, MD, discusses new formulations of ketamine for subcutaneous delivery and how ketamine works.

Dr Becker is cofounder and Chief Scientific Officer at Bexson Biomedical, Inc.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
Psychiatric Times Experts Weight in on FDA Advisory Decision for PTSD
New Africa /Adobestock
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Related Content
How effective are these agents for AUD treatment? An expert shares highlights from his 2024 ASCP Annual Meeting Pharmaceutical Pipeline Update presentation.
August 15th 2025

An Update on GLP-1 Receptor Agonists as Pharmacotherapies for AUD

Mehdi Farokhnia, MD, MPH
Erin Crown, MHS, PA-C, shares her thoughts on ASCP, the annual meeting, and more.
August 15th 2025

Research and Opportunities at the 2024 ASCP Annual Meeting

Erin Crown, MHS, PA-C, Psych-CAQ
Anita H. Clayton, MD, gives a preview of her upcoming poster presentation at the 2024 ASCP Annual Meeting.
August 15th 2025

Early Improvement of Symptoms in Bipolar 1 Depression

Anita H. Clayton, MD
Joseph F. Goldberg, MD, gives a preview of his upcoming panel presentation at the 2024 ASCP Annual Meeting.
August 15th 2025

Pseudospecific and Transdiagnostic Symptom Targeting in Clinical Trials

Joseph F. Goldberg, MD
Anita H. Clayton, MD, welcomes us all to the 2024 ASCP Annual Meeting!
August 15th 2025

Exciting Possibilities at ASCP 2024

Anita H. Clayton, MD
An expert shares highlights from her panel presentation at the 2024 ASCP Annual Meeting.
August 15th 2025

Navigating New Treatments for PTSD

Lori Davis, MD
© 2025 MJH Life Sciences

All rights reserved.